• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FINELINE II STEROX; PERMANENT PACEMAKER ELECTRODE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FINELINE II STEROX; PERMANENT PACEMAKER ELECTRODE Back to Search Results
Model Number 4457
Device Problems Failure to Capture (1081); Connection Problem (2900); High Capture Threshold (3266)
Patient Problem Unspecified Infection (1930)
Event Date 11/13/2021
Event Type  Injury  
Event Description
It was reported that two days following the device implant procedure, the right ventricular (rv) lead exhibited high, variable capture threshold measurements.There was some concern due to the patient's pacemaker dependency.At the one-week follow-up, the device was interrogated and there were multiple instances of loss of capture (loc) accompanied by coughing from the patient.The physician performed threshold testing which also elicited coughing.The patient indicated that since the device change procedure, he had been coughing more and feeling light-headed, which impacted physical activity.Additionally, the device wound pocket was still bleeding, which caused the physician cause for concern regarding a potential infection.The following day, the physician elected to perform a rv revision procedure.A fluoroscopy was performed which confirmed the rv lead was not inserted completely into the device header.The lead was disconnected from the device and tested using a pacemaker system analyzer which still demonstrated high capture threshold measurements.Due to the patient's dependency, the physician elected to surgically cap and abandon the rv lead.A new rv lead was subsequently implanted to resolve the event.At this time, the device remains implanted and in-service.The previous rv lead remains implanted, but capped and out-of-service.The patient was stable with no additional adverse effects.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FINELINE II STEROX
Type of Device
PERMANENT PACEMAKER ELECTRODE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key13386529
MDR Text Key284640838
Report Number2124215-2021-40507
Device Sequence Number1
Product Code DTB
UDI-Device Identifier00802526060915
UDI-Public00802526060915
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P960004/S014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/28/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date08/30/2014
Device Model Number4457
Device Catalogue Number4457
Device Lot Number726067
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/24/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/30/2012
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age41 YR
-
-